IP Library Granted Patent US 8,906,638
Granted Patent B2
US 8,906,638 · App. 13/884,475 · Granted Dec 9, 2014

Method for quantification of remnant-like lipoprotein cholesterol and kit for same

Inventor: Yuhko Hirao (Gosen, JP)
Assignee: Denka Seiken Co., Ltd.
C12Q1/60G01N33/92C12Q1/44G01N2333/918
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,906,638
App. No.
13/884,475
Granted
Dec 9, 2014
Kind
B2
Abstract

A method for quantifying remnant-like lipoprotein cholesterol in a sample simply and accurately without requiring separation operations, and a kit therefor are disclosed. A method for quantifying cholesterol in a remnant-like lipoprotein in a sample containing different lipoproteins including the remnant-like lipoprotein comprises a step (1) of erasing cholesterol in lipoproteins other than the remnant-like lipoprotein; and a step (2) of quantifying cholesterol in the remaining remnant-like lipoprotein. The step (1) is carried out under an action of a cholesterol esterase having a molecular weight of more than 40 kDa and not having a subunit having a molecular weight of not more than 40 kDa; and the step (2) is carried out under an action of a cholesterol esterase having a molecular weight of not more than 40 kDa or a cholesterol esterase having a subunit having a molecular weight of not more than 40 kDa.

Claims (8)

1. A method for quantifying remnant-like lipoprotein cholesterol in a sample containing different lipoproteins including the remnant-like lipoprotein, said method comprising:

step (1) decomposing cholesterol in lipoproteins in the sample except for cholesterol in the remnant-like lipoprotein by decomposing the cholesterol to make it undetectable in step (2); and

step (2) quantifying cholesterol in the remaining remnant-like lipoprotein,

wherein said step (1) is carried out under an action of a cholesterol esterase having a molecular weight of more than 40 kDa and not having a subunit having a molecular weight of 40 kDa or less; and said step (2) is carried out under an action of a cholesterol esterase having a molecular weight of 40 kDa or less or a cholesterol esterase having a subunit having a molecular weight of 40 kDa or less.

2. The method according to claim 1 , wherein said step (1) further comprises treating said sample with said cholesterol esterase and a cholesterol oxidase, and removing generated hydrogen peroxide of step (1); and said step (2) further comprises treating said sample with said cholesterol esterase and cholesterol oxidase, and quantifying generated hydrogen peroxide of step (2).

3. The method according to claim 1 or 2 , wherein said step (1) and said step (2) are carried out in the presence of a nonionic surfactant.

4. The method according to claim 1 , wherein a nonionic surfactant is used in said step (1) and said step (2), and wherein said nonionic surfactant comprises at least one selected from the group consisting of a polyoxyethylene derivative having an HLB value of 11 to 13, polyoxyethylene alkyl ether, polyoxyalkylene alkyl ether and polyoxyethylene alkyl phenyl ether.

5. The method according to claim 1 , wherein said step (1) further comprises treating said sample with a phospholipase.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBERS 10007286 AND 10415007 PREVIOUSLY RECORDED AT REEL: 054513 FRAME: 0142. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Dec 14, 2020
From: DENKA SEIKEN CO., LTD.
To: DENKA COMPANY LIMITED
Reel/Frame 055437/0045 →
MERGER Recorded Nov 24, 2020
From: DENKA SEIKEN CO., LTD.
To: DENKA COMPANY LIMITED
Reel/Frame 054513/0142 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 10, 2013
From: HIRAO, YUHKO
To: DENKA SEIKEN CO., LTD.
Reel/Frame 030394/0092 →
Priority Claims (1)
JP 2010-251511 · Nov 10, 2010 · national
Continuity (1)
Related Publication 20130230873A1 · Sep 5, 2013